Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

In this section

Oxford Medical Alumni Network

Sign up for mailings - keep in touch with medicine at Oxford.

Update your details - Make sure you receive alumni news and event invitations.

Medical Sciences Division News

An artist’s impression which shows the proposed new Warneford Park research building on the right and the new hospital on the left, with a link building in between.

Warneford Park: Mental health and medical research campus development gets green light from Oxford City Council

Plans to create a £750m mental health and medical research campus in Oxford have been given the go-ahead by Oxford City Council.

A seated woman talking to a female professional

New Oxford Centre for Women’s Mental Health established

The University of Oxford is set to launch a new research centre dedicated to women’s mental health, bringing together expertise from medical and biological sciences with humanities for the first time.

Illustration of kids using mobile phones

Expert Comment: Social media and AI chatbot limits for children - what does the evidence support?

This week the UK government announced a ban on social media for under-16s and new age limits on romantic and sexual AI chatbots, following the precedent set by Australia. Researchers from the University of Oxford's Department of Psychiatry welcome the focus on children's online safety, but argue that age limits alone are a limited safeguard, and that protecting children depends more on how platforms and AI systems are designed than on who can reach them.

Professor Adam Mead appointed as Director of Oxford Cancer

Oxford Cancer is delighted to announce the appointment of Professor Adam Mead as Director, joining Professors Mark Middleton and Tim Elliott in leading Oxford’s interdisciplinary cancer research community.

radiotherapy

New biomarker brings personalised Polθ inhibitor-radiotherapy treatment closer to the clinic

A new study led by Professor Geoff Higgins at the Department of Oncology, in collaboration with Artios Pharma, has uncovered a genetic vulnerability that could help identify patients most likely to benefit from a promising radiotherapy combination treatment. Published today in Science Advances, the research identifies loss of SHLD2 as a predictive biomarker for treatment with DNA polymerase theta (Polθ) inhibitors, an emerging class of DNA repair-targeted drugs.

More news